Showing 406 results

Filters Content type: News, Editors' picks Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Weight gain & lipodystrophy

Treatment changes do not reduce weight in people with HIV

News
17 July 2025
Treatment guidelines

US: Decline of Nonrecommended HIV Care in Medicare

Editor's pick
Medscape (requires free registration)
7 July 2025
Injectable & long-acting HIV treatment

Potential for bictegravir and dolutegravir to overcome resistance to CAB/RPV-LA

Editor's pick
i-Base
14 April 2025
Changing treatment

Dolutegravir resistance very rare after a switch - even with detectable HIV

News
8 July 2024
Weight gain & lipodystrophy

Switching from TAF to TDF leads to weight loss

News
23 April 2024
Drug interactions & pharmacokinetics

Small Study Finds No Need for Double-Dosing Dolutegravir After Switching From Failing Efavirenz-Based Regimen

Editor's pick
TheBodyPro
17 April 2024
Resistance

Widely used HIV drug in South Africa flagged for reports of resistance – but experts say don’t panic

Editor's pick
Spotlight
16 April 2024
Changing treatment

Voices from Zambia: Improving HIV Treatment with DRV/r

Editor's pick
Clinton Health Access Initiative
30 November 2023
Changing treatment

One Third of French Group Has Not Changed Antiretrovirals for Over 10 Years

Editor's pick
NATAP
27 October 2023
Changing treatment

Increasing and changing pattern of treatment switches among people with HIV

News
23 October 2023
Treatment simplification strategies

Reduced-drug treatment becoming common in Paris

News
23 October 2023
Weight gain & lipodystrophy

Weight Loss or Gain Predictors Hard to Find in INSTI-to-PI Switch Trial

Editor's pick
NATAP
19 October 2023
Hepatitis B

Hepatitis B Reactivation Risk Low in People With HIV Following Antiretroviral Switch

Editor's pick
Contagion Live
17 October 2023
Resistance

Resistance history does not affect response to dolutegravir / lamivudine

News
11 August 2023
Changing treatment

Adherence counselling reverses viral rebound on dolutegravir in 95% of cases

News
1 August 2023
Weight gain & lipodystrophy

Switches away from integrase inhibitors do not reverse weight gain, studies find

News
27 July 2023
HIV treatment for children & young people

NRTI-sparing regimen effective for children and adolescents

News
21 July 2023
Treatment simplification strategies

Dolutegravir alone maintains HIV suppression in those treated early

News
28 June 2023
Changing treatment

Second-Line Switch to Dolutegravir Noninferior in HIV

Editor's pick
HealthDay News
26 June 2023
Improving HIV care

Same-day viral load test installed in Uganda, but people with HIV still received results months later

News
20 June 2023
Treatment simplification strategies

Real-world data confirm the efficacy of dolutegravir-based dual therapy

News
29 May 2023
Injectable & long-acting HIV treatment

Study of Weekly Oral HIV Treatment Resumes

Editor's pick
POZ
8 May 2023
People with limited treatment options

Study Bite: Switching to B/F/TAF Plus Doravirine in Multidrug-Resistant PLWH

Editor's pick
TheBodyPro
5 May 2023
Injectable & long-acting HIV treatment

Clinic finds almost half of people who want long-acting HIV treatment don’t initiate it

Editor's pick
CATIE
30 March 2023